Birgit C. Schultes, EVP, Chief Scientific Officer at Intellia Therapeutics, Inc. (NTLA), sold 8,508 shares at $9.21 ($78K) on 2026-01-05, disclosed to the SEC on 2026-01-07.
Open-market sale of $78k NTLA by EVP, Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.